ono 1078 has been researched along with 3-(((3-carboxycyclohexyl)amino)carbonyl)-4-(3-(4-(4-phenoxybutoxy)phenyl)propoxy)benzoic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aratani, Y; Egashira, H; Fujita, M; Hisaichi, K; Ima, M; Imagawa, A; Inoue, A; Ishida, A; Itadani, S; Kadode, M; Kinoshita, A; Kitamine, T; Matsumura, N; Moriguchi, H; Nabe, T; Nakao, T; Nakayama, Y; Nomura, H; Ohmoto, K; Ohta, N; Sekiguchi, T; Sekioka, T; Tajima, Y; Takahashi, S; Takeuchi, J; Ueda, J; Yamaura, Y; Yashiro, K; Yonetomi, Y | 1 |
1 other study(ies) available for ono 1078 and 3-(((3-carboxycyclohexyl)amino)carbonyl)-4-(3-(4-(4-phenoxybutoxy)phenyl)propoxy)benzoic acid
| Article | Year |
|---|---|
Discovery of Gemilukast (ONO-6950), a Dual CysLT1 and CysLT2 Antagonist As a Therapeutic Agent for Asthma.
Topics: Animals; Asthma; Biological Availability; Butyrates; Dogs; Guinea Pigs; Humans; Indoles; Leukotriene Antagonists; Rats; Receptors, Leukotriene | 2015 |